Net Debt Summary of Novartis AG

Novartis AG's latest annual net debt in 2023 was 12.95 Billion USD , down -36.64% from previous year.
Novartis AG's latest quarterly net debt in 2024 Q3 was 16.7 Billion USD , down -11.98% from previous quarter.
Novartis AG reported annual net debt of 20.44 Billion USD in 2022, up 9.42% from previous year.
Novartis AG reported annual net debt of 18.68 Billion USD in 2021, down -34.18% from previous year.
Novartis AG reported quarterly net debt of 16.7 Billion USD for 2024 Q3, down -11.98% from previous quarter.
Novartis AG reported quarterly net debt of 21.07 Billion USD for 2024 Q2, up 18.48% from previous quarter.

Annual Net Debt Chart of Novartis AG (2023 - 1998)

Historical Annual Net Debt of Novartis AG (2023 - 1998)

Year	Net Debt	Net Debt Growth
2023	12.95 Billion USD	-36.64%
2022	20.44 Billion USD	9.42%
2021	18.68 Billion USD	-34.18%
2020	28.39 Billion USD	55.81%
2019	18.22 Billion USD	-3.18%
2018	18.81 Billion USD	-3.81%
2017	19.56 Billion USD	16.49%
2016	16.79 Billion USD	-2.68%
2015	17.25 Billion USD	133.58%
2014	7.38 Billion USD	-34.8%
2013	11.33 Billion USD	-20.06%
2012	14.17 Billion USD	-14.04%
2011	16.49 Billion USD	-6.43%
2010	17.62 Billion USD	60.01%
2009	11.01 Billion USD	120.41%
2008	4.99 Billion USD	2044.64%
2007	233 Million USD	-93.15%
2006	3.4 Billion USD	80.14%
2005	1.88 Billion USD	297.47%
2004	475 Million USD	371.43%
2003	-175 Million USD	23.25%
2002	-228 Million USD	89.45%
2001	-2.16 Billion USD	-29.25%
2000	-1.67 Billion USD	-172.98%
1999	2.29 Billion USD	94.95%
1998	1.17 Billion USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	17.78 Billion USD	37.3%
2024 Q3	16.7 Billion USD	-11.98%
2024 Q2	21.07 Billion USD	18.48%
2023 FY	12.95 Billion USD	-36.64%
2023 Q4	12.95 Billion USD	1.34%
2023 Q3	12.78 Billion USD	-26.76%
2023 Q2	17.45 Billion USD	1.46%
2023 Q1	17.2 Billion USD	-15.86%
2022 FY	20.44 Billion USD	9.42%
2022 Q4	20.44 Billion USD	3.21%
2022 Q1	17.48 Billion USD	-6.41%
2022 Q2	27.46 Billion USD	57.02%
2022 Q3	19.81 Billion USD	-27.86%
2021 Q1	34.04 Billion USD	19.9%
2021 Q2	30.72 Billion USD	-9.74%
2021 Q3	27.11 Billion USD	-11.75%
2021 FY	18.68 Billion USD	-34.18%
2021 Q4	18.68 Billion USD	-31.09%
2020 Q2	28.86 Billion USD	-10.25%
2020 Q3	29.18 Billion USD	1.08%
2020 Q4	28.39 Billion USD	-2.71%
2020 FY	28.39 Billion USD	55.81%
2020 Q1	32.16 Billion USD	76.54%
2019 FY	18.22 Billion USD	-3.18%
2019 Q1	23.78 Billion USD	26.38%
2019 Q2	20.27 Billion USD	-14.75%
2019 Q3	21.73 Billion USD	7.21%
2019 Q4	18.22 Billion USD	-16.18%
2018 Q2	19.91 Billion USD	-29.64%
2018 Q3	17.78 Billion USD	-10.69%
2018 FY	18.81 Billion USD	-3.81%
2018 Q4	18.81 Billion USD	5.83%
2018 Q1	28.29 Billion USD	44.63%
2017 Q3	21.35 Billion USD	-5.97%
2017 Q1	23.68 Billion USD	41.02%
2017 Q2	22.7 Billion USD	-4.14%
2017 Q4	19.56 Billion USD	-8.36%
2017 FY	19.56 Billion USD	16.49%
2016 Q4	16.79 Billion USD	-13.39%
2016 FY	16.79 Billion USD	-2.68%
2016 Q2	21.33 Billion USD	-9.75%
2016 Q3	19.39 Billion USD	-9.09%
2016 Q1	23.63 Billion USD	36.97%
2015 Q2	18.05 Billion USD	1.72%
2015 FY	17.25 Billion USD	133.58%
2015 Q4	17.25 Billion USD	-0.67%
2015 Q3	17.37 Billion USD	-3.78%
2015 Q1	17.75 Billion USD	140.25%
2014 Q2	13.63 Billion USD	-2.91%
2014 Q1	14.04 Billion USD	23.92%
2014 FY	7.38 Billion USD	-34.8%
2014 Q4	7.38 Billion USD	-25.87%
2014 Q3	9.96 Billion USD	-26.9%
2013 Q2	14.79 Billion USD	-29.36%
2013 Q3	12.41 Billion USD	-16.1%
2013 Q4	11.33 Billion USD	-8.71%
2013 FY	11.33 Billion USD	-20.06%
2013 Q1	20.94 Billion USD	47.76%
2012 Q1	24.59 Billion USD	49.14%
2012 Q2	22.63 Billion USD	-7.98%
2012 Q3	20.84 Billion USD	-7.92%
2012 Q4	14.17 Billion USD	-31.99%
2012 FY	14.17 Billion USD	-14.04%
2011 FY	16.49 Billion USD	-6.43%
2011 Q4	16.49 Billion USD	-30.98%
2011 Q3	23.89 Billion USD	-13.14%
2011 Q1	31.11 Billion USD	76.54%
2011 Q2	27.5 Billion USD	-11.6%
2010 FY	17.62 Billion USD	60.01%
2010 Q2	18.64 Billion USD	3.98%
2010 Q3	26.96 Billion USD	44.62%
2010 Q4	17.62 Billion USD	-34.63%
2010 Q1	17.92 Billion USD	62.78%
2009 FY	11.01 Billion USD	120.41%
2009 Q3	14.36 Billion USD	3.58%
2009 Q1	11.45 Billion USD	129.18%
2009 Q2	13.86 Billion USD	21.11%
2009 Q4	11.01 Billion USD	-23.33%
2008 Q3	2.66 Billion USD	148.78%
2008 Q4	4.99 Billion USD	87.36%
2008 Q1	-4.37 Billion USD	-1975.97%
2008 Q2	-5.46 Billion USD	-25.07%
2008 FY	4.99 Billion USD	2044.64%
2007 Q3	-7.28 Billion USD	-7414.43%
2007 FY	233 Million USD	-93.15%
2007 Q4	233 Million USD	103.2%
2007 Q1	393 Million USD	-88.44%
2007 Q2	-97 Million USD	-124.68%
2006 Q3	691 Million USD	-67.34%
2006 Q1	-3.02 Billion USD	-260.12%
2006 Q4	3.4 Billion USD	392.19%
2006 Q2	2.11 Billion USD	170.0%
2006 FY	3.4 Billion USD	80.14%
2005 FY	1.88 Billion USD	297.47%
2005 Q4	1.88 Billion USD	280.67%
2005 Q3	-1.04 Billion USD	40.15%
2005 Q1	-6.23 Billion USD	-1412.63%
2005 Q2	-1.74 Billion USD	72.0%
2004 FY	475 Million USD	371.43%
2004 Q2	2.41 Billion USD	-26.64%
2004 Q1	3.29 Billion USD	1983.43%
2004 Q4	475 Million USD	-79.8%
2004 Q3	2.35 Billion USD	-2.77%
2003 Q1	-95 Million USD	58.33%
2003 Q2	2.41 Billion USD	2643.16%
2003 FY	-175 Million USD	23.25%
2003 Q3	940 Million USD	-61.09%
2003 Q4	-175 Million USD	-118.62%
2002 Q3	-5.41 Billion USD	31.06%
2002 Q2	-7.85 Billion USD	0.0%
2002 Q4	-228 Million USD	95.79%
2002 FY	-228 Million USD	89.45%
2001 Q2	1.68 Billion USD	0.0%
2001 FY	-2.16 Billion USD	-29.25%
2001 Q4	-2.16 Billion USD	0.0%
2000 Q2	1.67 Billion USD	0.0%
2000 Q4	-1.67 Billion USD	0.0%
2000 FY	-1.67 Billion USD	-172.98%
1999 FY	2.29 Billion USD	94.95%
1998 FY	1.17 Billion USD	0.0%

Peer Net Debt Comparison of Novartis AG

Name	Net Debt	Net Debt Difference
AstraZeneca PLC	22.74 Billion USD	43.055%
Bristol-Myers Squibb Company PFD CONV 2	30 Billion USD	56.817%
CSPC Pharmaceutical Group Limited	-1.59 Billion USD	912.715%
Clarus Therapeutics Holdings, Inc.	15.85 Million USD	-81614.394%
PT Kalbe Farma Tbk.	-169.7 Million USD	7733.989%

Global Stocks Search

Novartis AG (NVSEF)

Net Debt Summary of Novartis AG

Annual Net Debt Chart of Novartis AG (2023 - 1998)

Historical Annual Net Debt of Novartis AG (2023 - 1998)

Peer Net Debt Comparison of Novartis AG